Brand new report "Drug Delivery Technologies: Commercial Prospects 2010-2025" by Visiongain Ltd.

Oct. 8, 2010 - PRLog -- Report Details
- how you can find clinical performance and lifecycle management opportunities there

How will the drug delivery sector develop from 2010, and where will you find the greatest opportunities? How will technology suppliers and drug companies benefit? We show you opportunities for revenue growth for suppliers and users of drug delivery technologies. You can have our report today, staying ahead.

Our new report shows you trends to watch. Novel and generic drug producers can benefit from emerging and established drug delivery technologies. Developments will occur for biotech drugs and small-molecule agents. We analyse commercial trends for:
• Oral drug delivery systems
• Inhalation-based systems
• Transdermal systems
• Injectable systems
• Implanted systems
• Ocular and nasal systems.

The market for drug delivery technologies has been growing rapidly, but which segments will grow fastest? What are the commercial trends to watch? How will the worldwide industry and market perform from 2010 to 2025? Our report answers those and other questions about this important pharma and biotech sector.

We show how you can benefit from the sector. There remain unmet therapeutic needs. Drugs with improved delivery can gain significant market shares from 2010 onwards, increasing competitiveness and extending product lifecycles.

The drug delivery industry and market can expand from 2010 onwards. Our report shows how you could benefit, saving your time and aiding your work. We show you opportunities by therapeutic area.

You can find out how the drug delivery technology market will grow and study trends that are driving this sector. Our study will show you its technological and commercial potential from 2010 onwards.

Industry and market analysis to save you time and aid your decisions

Our new report examines the drug delivery sector critically. We harness primary and secondary research to meet your needs. We provide revenue forecasts, market share analyses, pipeline developments and other data. You can discover strengths, weaknesses, opportunities and threats in the sector. We include 90 tables and figures and two expert interviews - shown in the contents lists with this message.

How you can benefit from Drug Delivery Technologies: Commercial Prospects 2010-2025

Our report gives you the following benefits in particular:
• You will receive hard data for the drug delivery sector, including our revenue predictions for 2010 to 2025
• You will discover revenue analyses for the overall market and its main components from 2009 to 2025, helping you to stay ahead
• You will discover revenue trends for leading national markets from 2009 to 2025 (US, Japan, UK, Germany, France, Spain, Italy, China and India)
• You will find out how the sector will change and adapt from 2010 to 2025
• You will assess leading organisations in drug delivery, discovering their activities and prospects
• You will investigate the drivers, restraints, competition and opportunities influencing drug delivery technologies from 2010 onwards
• You will analyse opportunities for established companies and new market entrants
• You will receive expert views from our survey, including interview transcripts
• You will find out where drug delivery is heading - technologically and commercially - from 2010 onwards.

Our study gives you answers and trends - we aim to save you time and aid your decisions.

You can have this report today

Our new report can benefit everybody interested in drug delivery and related technologies. We forecast commercial potential, discovering trends. Do you want to harness those opportunities? You can stay ahead by ordering our report now. Please let us know how we can help.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Conatact Person:

Bijal Patel
bijal.patel@visiongainglobal.com
0044(0)20 7549 9946

# # #

Visiongain is an independent business information provider for the Telecoms, Pharmaceutical and Defence industries. We organise conferences, publish reports and newsletters, and provide consultancy services.